Chen Sun
FDA investigator
Appears on 3 documents from 2019 to 2022, most often at sites in France. Most often cites production record review (21 CFR 211.192).
- 3
- Documents on file
- 2.7
- Observations per 483
- 2019
- First seen
- 2022
- Most recent
What they cite most
From 8 observations- 21 CFR 211.192Production record review3
- 21 CFR 211.160General requirements2
- 21 CFR 211.67Equipment cleaning and maintenance2
- 21 CFR 211.56Sanitation1
Activity by year
2019: 1, 2021: 1, 2022: 1
Where
France 1 · Japan 1 · South Korea 1
Often inspects with
Is Chen Sun coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
3 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2022-05-24 | 483 Merck BiodevelopmentMay 24, 2022 · Martillac, France | Martillac, France | 3 | |
| 2021-08-24 | 483 Samsung Biologics Co., Ltd. 300 Songdo bio-daero, Yeonsu-guAug 24, 2021 · Incheon, South Korea | Incheon, South Korea | 1 | |
| 2019-10-04 | 483 Kyowa Kirin Co., Ltd.Oct 4, 2019 · Takasaki-shi, Japan | Takasaki-shi, Japan | 4 |
About this profile
What does Chen Sun inspect?
Chen Sun appears on 3 documents on file covering 3 sites, most often in France.
What do they cite most often?
21 CFR 211.192 (production record review), followed by 21 CFR 211.160 and 21 CFR 211.67.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Chen Sun is dated May 24, 2022.